山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2015年
20期
18-21
,共4页
赵静静%王伟灵%邢嘉翌%张莹%杨沁彤%赵延荣
趙靜靜%王偉靈%邢嘉翌%張瑩%楊沁彤%趙延榮
조정정%왕위령%형가익%장형%양심동%조연영
糖尿病足%脂蛋白(a)%半胱氨酸蛋白酶抑制剂C%湿热毒盛%脾肾阳虚%经脉不通
糖尿病足%脂蛋白(a)%半胱氨痠蛋白酶抑製劑C%濕熱毒盛%脾腎暘虛%經脈不通
당뇨병족%지단백(a)%반광안산단백매억제제C%습열독성%비신양허%경맥불통
diabetic foot%lipoprotein ( a)%cysteine proteinase inhibitor C%dampness-heat type%yang deficiency of spleen and kidney%meridian barrier
目的:检测糖尿病足(DF)患者血清脂蛋白(a)[Lp(a)]和半胱氨酸蛋白酶抑制剂C(Cys C)水平,分析两指标与DF湿热毒盛证和脾肾阳虚、经脉不通证两种证型的关系。方法选择DF湿热毒盛证患者139例( A组),DF脾肾阳虚、经脉不通证患者46例(B组)和单纯T2DM患者78例(C组)。采集空腹静脉血,测定各组血清Lp(a)、Cys C,并对结果进行分析。结果各组血清Lp(a)、Cys C水平比较,A、B组高于C组,B组高于A组,P<0.05或<0.01。单因素Logistic回归分析显示,Lp(a)和Cys C是DF脾肾阳虚、经脉不通证的危险因素(P均<0.05);多因素Logistic回归分析显示,Lp(a)为DF脾肾阳虚、经脉不通证的独立危险因素(P<0.05)。结论 DF患者血清Lp(a)和Cys C水平显著升高,Lp( a)和Cys C可能参与了DF脾肾阳虚、经脉不通证患者大血管病变的发生、发展。
目的:檢測糖尿病足(DF)患者血清脂蛋白(a)[Lp(a)]和半胱氨痠蛋白酶抑製劑C(Cys C)水平,分析兩指標與DF濕熱毒盛證和脾腎暘虛、經脈不通證兩種證型的關繫。方法選擇DF濕熱毒盛證患者139例( A組),DF脾腎暘虛、經脈不通證患者46例(B組)和單純T2DM患者78例(C組)。採集空腹靜脈血,測定各組血清Lp(a)、Cys C,併對結果進行分析。結果各組血清Lp(a)、Cys C水平比較,A、B組高于C組,B組高于A組,P<0.05或<0.01。單因素Logistic迴歸分析顯示,Lp(a)和Cys C是DF脾腎暘虛、經脈不通證的危險因素(P均<0.05);多因素Logistic迴歸分析顯示,Lp(a)為DF脾腎暘虛、經脈不通證的獨立危險因素(P<0.05)。結論 DF患者血清Lp(a)和Cys C水平顯著升高,Lp( a)和Cys C可能參與瞭DF脾腎暘虛、經脈不通證患者大血管病變的髮生、髮展。
목적:검측당뇨병족(DF)환자혈청지단백(a)[Lp(a)]화반광안산단백매억제제C(Cys C)수평,분석량지표여DF습열독성증화비신양허、경맥불통증량충증형적관계。방법선택DF습열독성증환자139례( A조),DF비신양허、경맥불통증환자46례(B조)화단순T2DM환자78례(C조)。채집공복정맥혈,측정각조혈청Lp(a)、Cys C,병대결과진행분석。결과각조혈청Lp(a)、Cys C수평비교,A、B조고우C조,B조고우A조,P<0.05혹<0.01。단인소Logistic회귀분석현시,Lp(a)화Cys C시DF비신양허、경맥불통증적위험인소(P균<0.05);다인소Logistic회귀분석현시,Lp(a)위DF비신양허、경맥불통증적독립위험인소(P<0.05)。결론 DF환자혈청Lp(a)화Cys C수평현저승고,Lp( a)화Cys C가능삼여료DF비신양허、경맥불통증환자대혈관병변적발생、발전。
Objective To detect the levels of lipoprotein ( a) [ Lp( a) ] and cysteine proteinase inhibitor C ( Cys C) in serum of patients with diabetic foot (DF), and to analyze the correlations of two indicators with dampness-heat type, yang deficiency of spleen and kidney combined with meridian barrier type .Methods A total of 139 patients with damp-ness-heat type ( group A ) , 46 patients with yang deficiency of spleen and kidney combined with meridian barrier type (group B) and 78 patients with type 2 diabetes mellitus (T2DM) (group C) were enrolled.Fasting blood were collected for the determinations of Lp(a) and Cys C.The results were analyzed statistically.Results The levels of Lp(a) and Cys C in the group A and group B were significantly higher than those in the group C , and two indicators in the group B were significantly higher than those in the group A (P<0.01 or P<0.05).Univariate Logistic regression analysis showed that Lp( a) and Cys C were risk factors for yang deficiency of spleen and kidney combined with meridian barrier type of DF ( all P<0.05).Multivariate Logistic regression analysis showed that Lp (a) was the independent risk factor for yang deficiency of spleen and kidney combined with meridian barrier type of DF (P<0.05).Conclusions The Lp(a) and Cys C levels in the serum are significantly increased in DF patients , which indicates that Lp ( a) and Cys C may participate in the occur-rence and development of microangiopathy of DF patients with yang deficiency of spleen and kidney combined with meridian barrier type .